R&D + Strategic Partnering
for the Global Vaccine Industry

Cedric Bogaert cofounded myNEO, whose software uses neural networks trained on biological datasets to figure out the best personalized cancer immunotherapies for a given patient. myNEO focuses on neoantigen targets it identifies from the genomic profile of the tumor sample. Based on promising...

Andrew first studied as a virologist at the University of Warwick before then furthering his education with postgraduate studies in influenza replication at Oxford University. Since then he has applied his scientific knowledge in a commercial setting. After working as part of a multidisciplinary...

Mark A. Emalfarb is the founder of Dyadic. He has been a member of Dyadic's board of directors since October 2004 and has served as its Chairman as well as President and Chief Executive Officer from October 2004 until April 2007 and from June 2008 until the present. Since founding Dyadic in...

Marion Gruber is the Vice President for Public Health and Regulatory  Science at the International AIDS Vaccine Initiative (IAVI).  In this role she is leading the development and execution of IAVI’s public health and regulatory science efforts to advance IAVI’s product development programs in...

Dr. Ali Harandi is currently affiliated to Sahlgrenska Academy at University of Gothenburg in Sweden and holds a visiting faculty position at Vaccine Evaluation Center, University of British Columbia in Canada.  Dr. Harandi was awarded the prestigious Heine-Medin medal by European Society for...

Dr. Keirstead is an internationally known stem cell expert and has led therapy development for late stage cancers, immune disorders, motor neuron diseases, spinal cord injury and retinal diseases. He is the CEO of AIVITA Biomedical. He was previously CSO of Caladrius which acquired California Stem...

Alexandre is a serial entrepreneur with a fascination for biology and more than 20 years of experience in healthcare ranging from research and development to commercialization of vaccines and therapeutics.He has led several biotech companies in Europe and the US including his current position at...

Geert Leroux-Roels obtained the MD degree from the Ghent University in 1976. He completed a specialty training in internal medicine and conducted doctoral research in clinical pathology and immunology. In 1981 he was board certified in internal medicine and a obtained a PhD degree in biomedical...

Shanti Pather heads up Global Medical Affairs department at BioNTech SE, the manufacturer and developer of the world’s first COVID-19 vaccine and first approved mRNA vaccine, BNT162b2.Prior to joining BioNTech, Shanti held various leadership roles in the pharmaceutical and biotechnology industry...

Ruben Rizzi, physician by training, VP of Global Regulatory Affairs at BioNTech. I joined the company in December 2019 just before the pandemic, and I have been the global regulatory lead for BioNTech for our COVID-19 development. Currently, I am still supporting the lifecycle of our COVID-19...

Nigel Temperton received a PhD from the London School of Hygiene and Tropical Medicine (London), post-doctoral training at UCL (London) and is currently Full Professor and Chair of Molecular Virology at the University of Kent, and Director of the Viral Pseudotype Unit (VPU). He is an educator in...

Dr. Maria Elena Bottazzi is an internationally recognized tropical and emerging disease vaccinologist, global health advocate and cocreator of a patent-free, open science COVID-19 vaccine technology that led to the development of Corbevax in India and IndoVac in Indonesia, and with approximately...

Dr. Christensen was recently appointed as Global Head of R&D for Adjuvant Systems at Croda Pharma after 18 years in adjuvant research at Statens Serum Institut, Denmark. During his career, his research focus has been on pharmaceutical and immunological aspects of vaccine adjuvants and delivery...

Dr. Ed Kelley is the Chief Global Health Officer at ApiJectHe recently left his position as the World Health Organization’s Director of Integrated Health Services, where he helped lead the organization’s COVID-19 response, creating WHO’s first public-private collaboration working directly with the...

Dr. Ofer Levy is principal investigator, staff physician and the Director of the Precision Vaccines Program at Boston Children’s Hospital, Professor of Pediatrics at Harvard Medical School, and Associate Member of the Broad Institute of MIT and Harvard. The Precision Vaccines Program (PVP) is an...

Haiko Pillu obtained a Professional Bachelor’s degree in Pharmaceutical andBiological Technology, and started his career in the Lab for Microbiology,Parasitology and Hygiene at the University of Antwerp. He joined SGS in July2006 to lead a group of freelance Lab Technicians and to develop the...

Dr. Jerald Sadoff, M.D. as Chief Medical Officer with immediate effect. Dr. Sadoff has more than fifty years of experience in vaccine development. He has overseen or played a key role in the approval of more vaccines than any other currently active vaccine developer, including vaccines against...

Walter Straus serves as Vice President and Clinical Safety Lead at Moderna Therapeutics. In this capacity, his team leads safety assessment for the company’s COVID-19 vaccine program, from clinical development through post-authorization responsibilities globally. Prior to joining Moderna in...

Antonio Garcia Maldonado is an Principal at SIF. He works on international investments with a focus on biotech in Europe and Israel, and tech-enabled service/product delivery in South Asia and Sub-Saharan Africa. Prior to joining the foundation, Antonio worked in the investment banking division at...

Francesco Pappalardo was born in Catania on 11 March 1975. He graduated in Computer Science with 110/110 cum laude on 2000 at the University of Catania; after graduating, in 2004 he obtained the title of Doctor of Philosophy (PhD) in Computer Science. From 2004 to 2011 he was a research fellow at...

Dr. Caldwell is the Associate Vice President, Vaccine Research & Education at Meharry Medical College in Nashville TN. He leads the emerging partnership between Meharry and Clinical Research Associates of Nashville and is a devoted clinician and teacher. Dr. Caldwell serves as an investigator...

Dr Ewer is an expert in the human immune response to vaccination and specialises in understanding how immunity translates into protective efficacy. She undertook her PhD on the immunology of T cell responses to TB and co-developed a diagnostic assay for the early detection of TB infection. She has...

Dr. Lenny Moise, VP Research, manages client projects and scientific development of the SeromYx Systems Serology platform for clinical research and drug discovery in infectious disease, immuno-oncology, autoimmunity and neurology. Prior to joining SeromYx, Lenny was Director of Vaccine Research at...

Dr. Hanna Nohynek (b. 1958) received her MD and PhD degree in the University of Helsinki Finland. She holds special expertise of International Health and Travel Medicine of the Finnish Medical Association. She presently works as Chief Physician in the Department of Health Security in the Finnish...

Aaron was born and raised in Bloomfield Hills, MI. He attended the Cranbrook educational community from grades K-12. He traveled west to study chemistry at the California Institute of Technology where he was introduced to boundary-breaking research in the Tirrell lab. After completing his...

Mark did graduate work in molecular immunology at Oxford University Institute of Molecular Medicine and Southampton University Cancer Sciences. In his postdoctoral work at MIT he developed tools in chemical biology, advanced microscopy and nanotechnology to understand receptor trafficking. He...

Robert Paris is VP, Therapeutic Area Head, Infectious Diseases at Moderna where he leads clinical development for its latent virus portfolio of vaccines include cytomegalovirus, herpes zoster, genital herpes, and Epstein-Barr virus programs as well as Translational Medicine studies. He initially...

A veterinarian by training, after completing my PhD at The Pirbright Institute in 1993 I became Head of the International FMD Vaccine Bank and held the position for 4 years. I moved to Pfizer AH in Sandwich, England in 1997 and eventually became Director of Biologicals Research for Europe, Africa...

Dr. Wolfe currently serve as the Branch Chief for the Vaccine Program in support of the CBRN Division of the Biomedical Advanced Research and Development Authority (BARDA). In doing so, he leads the advanced development and management of complex vaccine projects targeting biological threats. The...

Dr. Chad Costley has served as CEO&President of BlueWillow Biologics since 2020 after serving on the company's board of directors for several previous years. He is responsible for the development and execution of the company's operations and strategic initiatives related to its vaccine...

Ingrid de Visser - Kamerling (1975) graduated in Medical Biology from Leiden University in 1998. She subsequently worked at CHDR as a project leader and PhD student. She obtained her PhD from Leiden University in 2003 and became a registered clinical pharmacologist in 2005. From 2004 to 2007, she...

Professor Anne Moore holds a joint position between the School of Biochemistry and Cell Biology, UCC and the National Institute of Bioprocessing Research and Training (NIBRT). She brings to this joint appointment a wealth of expertise in immunology, bioprocessing, and vaccine development. Professor ...

Roland Zahn is currently Head of Nonclinical and Translational Immunology for Viral Vaccines at Janssen Vaccines and Prevention B.V.. In this role, he leads a team of researchers responsible for all aspects of nonclinical research on viral vaccines, for new vaccines entering the clinical...

Dr. Zaks, M.D., Ph.D., is a partner at OrbiMed Advisors LLC since November 2021. From 2015 to September 2021, he served as Chief Medical Officer of Moderna, Inc. From 2010 to 2015, he held senior development positions at Sanofi, including Senior Vice President and Head of Global Oncology. From...

James F. Cummings, M.D., FACP, FIDSA, FASTMH  has served as Chief Medical Officer at Vaxart since August 2021 and is responsible for all clinical vaccine development.. Preceding his role at VAXART, Dr. Cummings served as President of ICON Government and Public Health Solutions, Inc., a global...

Dr. Irina Meln is a Senior Innovation Manager at the European Vaccine Initiative (EVI), in Heidelberg, Germany. Irina develops, secures funding, and leads large collaborative projects leveraging public-private partnerships to increase innovations in the vaccine field. Irina has a scientific...

Professor Petro Terblanche has a successful track record in the strategic and operational management of technology intensive organizations. She has played a key part in the design and implementation of South Africa’s biotechnology strategy. She holds the position of Managing Director of Afrigen...

Chris joined Biologics Consulting as a Senior Consultant in 2015 after 2 years as an independent CMC consultant and more than 25 years of experience in the development, manufacturing, and quality control of clinical and commercial biopharmaceutical products, as well as IVDs. Fourteen of those years ...

Dr. Juliana Cassataro leads a research group on Immunology, infectious diseases, and vaccine development at the UNSAM Biotechnology Research Institute. She is currently Principal Investigator of CONICET and Associate Professor at UNSAM.There, the team studies the usefulness of different compounds...

Dr. Martin Friede is the Coordinator of the Initiative for Vaccine Research (IVR) at the World Health Organization (WHO) in Geneva, Switzerland, a position he has held since September 2016. In this role, Dr. Friede provides leadership to WHO's activities on vaccine research, including product...

Dr. Paul Gillard is a seasoned professional in the field of vaccine development. An alumnus of the University of Brussels where he acquired his medical in ‘93 and internal medicine in ‘98 degrees, Dr. Gillard has dedicated over 18 years to the clinical development of prophylactic...

Trang Gisler has over 20 years of scientific/technical, IT and business management experience in both the public and private sector with key emphasis in digital health, clinical trials, vaccine, and program management. She brings with her extensive experience in managing large portfolios for US...

Professor Munir Iqbal is the Head of the Avian Influenza and Newcastle Disease group at The Pirbright Institute and a visiting professor at the Royal Veterinary College, London. Munir obtained Veterinary Medicine and MPhil degrees in Pakistan and a PhD in Biotechnology at Imperial College London in ...

Tim Peterson is Associate Director, Product and Process Development at Kindeva Drug Delivery’s Woodbury, MN, headquarters, guiding Kindeva’s innovations in complex drug delivery. He has been developing and scaling up transdermal and microneedle-enabled drug delivery systems for over 30 years. Prior ...

Dr Pore is one of the co-founders of Intox Pvt. Ltd and looks over the responsibility of Executive Director and Test Facility Management. Dr Pore is a Diplomate of the American Board of Toxicology (DABT) and also European Registered Toxicologist (ERT) since 2009.   ​Dr Pore has designed and...

Dr. Marco Pravetoni holds the Rick L. Seaver Endowed Professorship in Brain Health, and he is a Professor of Psychiatry and Behavioral Sciences, Professor of Pharmacology, and Director of the Center for Medication Development for Substance Use Disorders and Overdose at the University of Washington...

Melanie Saville, MBBS, is PATH’s Chief Scientific Officer. She leads PATH’s product development division, which includes a global team dedicated to the development, introduction, and scale of vaccines, medical devices, and diagnostics. Dr. Saville is a distinguished physician specializing in...

Dr. Joe Smyser is the CEO of PGP (The Public Good Projects), a public health nonprofit specialized in large-scale media monitoring programs, SBCC programs, and cross-sector initiatives. PGP is a central figure in combating vaccine hesitancy and misinformation. For the past five years, PGP has...

Professor Tom Solomon CBE has been working on emerging infections of pandemic potential for nearly thirty years, with research programmes in Asia, Africa, Latin America, and the UK. He is Professor of Neurological Science and Head of the Brain Infections Group at the University of Liverpool. He...

Dr. Uchida is a professor at Tokyo Medical and Dental University and the Chief Medical Officer of Crafton Biotechnology. He leads interdisciplinary research that bridges the fields of medicine and engineering. After graduating from the University of Tokyo Medical School, Dr. Uchida began his career ...

Dr Thomas Waite is the Deputy Chief Medical Officer leading on health protection. His role covers emergency response and preparedness, infectious diseases, vaccines and therapeutics. Dr Waite is a consultant epidemiologist and completed his clinical and public health training in south Wales. He is ...

Nico holds a degree Business Engineering and obtained a PhD in Operations Research and Operations Management from KU Leuven in 1996. As full professor at KU Leuven, he is holder of the GSK Research Chairs on Access-to-Medicines, the Janssen Pharmaceutica Research Chair on Pandemic Preparedness and...

Dr. Maya Cabot has been associated with the development of several innovative virology research tools at Integral Molecular. These include Reporter Virus Particles (RVPs) and Influenza TiterSafe™ VLPs, contributing to the advancement of antiviral research and vaccine development. Maya earned her...

Margherita Coccia is a Director for Adjuvant Science and Technology at GSK. She received a M.Sc. in Biotechnology from the University San Raffaele in Milan and a PhD in Immunology from the Dunn School of Pathology at Oxford University. She has more than 10 years of experience in the science of...

Dr. de Jongh has a M.Sc. in Chemical Engineering from the University of Stellenbosch, South Africa and was awarded a doctorate in Biotechnology from the Technical University of Denmark (DTU). Furthermore, he was awarded an affiliated associate professorship at DTU in 2017. Dr. de Jongh has 18 years ...

Dr. Kyle Doolan leads cross-functional teams in molecular biology, protein engineering and virology that perform experiments for operations and research and development. Kyle has been instrumental in enhancing the performance of Integral Molecular’s technologies, and is an inventor on two of the...

As Chief Scientific Officer, Michael is responsible for LimmaTech’s scientific development, focusing on pipeline development and operational R&D performance. Michael has a PhD in Biochemistry from the Swiss Federal Institute of Technology, Zurich (ETH Zurich) and developed a broad experience in ...

Marie-Louise Lunn is Global Product Manager at Novo Nordisk Pharmatech with on enzymes for bioprocessing. She holds a Ph.D. in molecular biology and drug discovery from the University of Copenhagen, Denmark. After working as a postdoctoral researcher at the Salk Institute for Biological Studies in...

Mojca Tajnik Sbaizero is Head of Product Application Area at Sartorius BIA Separations, Slovenia. She is a biotechnologist and holds a PhD in Biomedicine-Genetics. She is employed in the company for 8 years and during this time she led several projects in downstream process development in the...

Hello everyone, my name is Jonathan Dodd I am a T cell immunologist with 28 years' experience working in both academia and industry. My career drive and motivation are to develop the ultimate assay repertoire that provides as accurate, precise, and complete a data set as possible, to determine...

Dr. Faissol is the program lead for predictive design of biologics at Lawrence Livermore National Laboratory (LLNL) and the PI of the Generative Unconstrained Intelligent Drug Engineering program, which focuses on the computational design of antibodies and antigens. His primary research interest is ...

Nektaria Karavas is the Global Director of Business Development for Nasal Vaccines, Antivirals and Immuno-stimulants at Aptar Pharma. Ms. Karavas joined Aptar Pharma in 2004 and has held various commercial roles executing long-term strategy within key customer and global accounts in North America...

Taylor has a Master’s in Public Health (MPH) from the University of North Texas Health Science Center and a B.S. from Texas A&M University. He is adjunct public health faculty at Texas A&M University and maintains his board certification by the National Board of Public Health Examiners. ...

Dr. Julie D. Suman is the Vice President of Scientific Affairs for Aptar Pharma. She manages strategic scientific planning and Aptar’s Scientific Advisory Board. Dr. Suman is also the co-founder of Next Breath. She holds a B.S. in Pharmacy from Duquesne University (1996) and a Ph.D. in...

Dr. Nicolas Burdin serves as Global Head of R&D at Clover. Dr. Burdin has spent over 27 years in vaccine research and development (R&D) with increasing responsibility roles at Sanofi, contributing to the successful progression of multiple prophylactic and therapeutic projects against...

Dr. Cooke has over thirty years of experience in the biopharmaceutical industry with a focus on vaccines.  He was previously CEO of NovaDigm Therapeutics, CEO of Mojave Therapeutics, COO at AVANT Immunotherapeutics, and SVP at Ology Bioservices. Prior to his leadership roles in the biotechnology...

Gautam Sanyal is a scientific leader in development of analytical and biophysical methods that are essential to batch release and characterization of vaccines and biopharmaceuticals. His expertise extends to rational formulation design, as demonstrated by delivery of several safe and effective...